Fragmentation of colicins A and E1 by cell surface proteases

Colicins are antimicrobial proteins produced by Escherichia coli that target and kill related bacteria. Prior research has shown that colicins interact with the bacterial cell surface and are taken up via specific receptors. However, the role of proteolysis in colicin activity remains unclear. Some studies suggest that colicin activity may be influenced by cell surface enzymes, but the extent and mechanism of this interaction is not fully understood. No prior work had resolved whether proteolysis is essential for colicin function. This gap motivated the investigation into whether proteases on the bacterial surface are involved in colicin inactivation. The study aimed to clarify the relationship between colicin-receptor binding and proteolytic cleavage. The authors sought to determine if receptor binding is reversible and if protease activity is localized to specific cell envelope fractions. This work builds on prior knowledge of colicin mechanisms and expands the understanding of bacterial surface interactions.

The study aimed to investigate the interaction of colicins A and E1 with Escherichia coli cell surfaces and determine the role of proteases in colicin cleavage and inactivation. The researchers wanted to assess whether proteolysis is necessary for colicin toxicity or if it serves another function. They also sought to identify the location of proteolytic activity within the bacterial cell envelope. The motivation stemmed from the lack of clarity about whether colicin proteolysis is essential for its antimicrobial function. The study aimed to test if receptor binding is reversible and if protease activity is linked to specific cell envelope fractions. The researchers focused on colicins A and E1 due to their well-characterized interactions with E. coli. The goal was to determine the relationship between colicin cleavage and its biological activity. The findings could help clarify the mechanisms of colicin action and bacterial resistance.

The researchers incubated colicins A and E1 with E. coli cells and analyzed the resulting supernatants for peptide fragments. They used gel electrophoresis to determine the molecular weight of cleavage products. Protease activity was tested by measuring the effect of P-aminobenzamidine on colicin cleavage. The outer membrane fraction of the cell envelope was isolated to assess proteolytic activity. A series of resistant mutants were examined to determine if colicin receptors are involved in proteolysis. The cleavage patterns of colicins were compared across different mutant strains. The researchers tested whether colicin fragments retained antimicrobial activity. They also assessed whether colicin binding to receptors is reversible by measuring adsorption and release.

Colicins A and E1 were cleaved into multiple fragments with molecular weights between 10,000 and 30,000. P-aminobenzamidine inhibited cleavage and increased colicin killing activity. Cleavage products were inactive against sensitive E. coli cells. Proteolytic activity was localized primarily to the outer membrane fraction. At least two distinct protease activities were identified. Colicin cleavage was not essential for its antimicrobial activity. Receptor binding was found to be reversible in resistant mutants. The data suggest that proteolysis does not play a necessary role in colicin toxicity.

The authors concluded that proteolysis of colicins A and E1 is not essential for their antimicrobial activity. Protease inhibitors increased colicin toxicity, indicating that cleavage may reduce effectiveness. Cleavage products lacked antimicrobial activity, supporting the idea that intact colicins are more potent. Proteolytic activity was concentrated in the outer membrane fraction. At least two protease activities were present in the cell envelope. Colicin binding to receptors was reversible, as shown by experiments with resistant mutants. Receptor binding and proteolysis appear to be separate processes. The findings suggest that colicin activity is not dependent on surface proteases.